FCMV
AGIO icon

Foresite Capital Management VI’s Agios Pharmaceuticals AGIO Stock Holding History

Foresite Capital Management VI’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.1M Buy
785,000
+260,000
+50% +$7.89M 4.53% 6
2026
Q1 		$17.8M Sell
525,000
-5,000
-0.9% -$142K 3.86% 6
2025
Q4 		$14.4M Buy
+530,000
New +$18.6M 4.36% 8

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Foresite Capital Management VI's AGIO Position: Q2 2026 in Review

Foresite Capital Management VI increased its Agios Pharmaceuticals (AGIO) stake by 50% in Q2 2026, buying an estimated $7.89M and bringing the position to 785,000 shares worth $29.1M. The position accounts for 4.53% of the portfolio, ranked #6.

Foresite Capital Management VI first reported a position in AGIO in Q4 2025 and has held it in 3 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Foresite Capital Management VI held 785,000 shares of Agios Pharmaceuticals worth $29.1M as of Q2 2026.
  • Foresite Capital Management VI bought 260,000 Agios Pharmaceuticals shares in Q2 2026, an estimated $7.89M.
  • Agios Pharmaceuticals made up 4.53% of Foresite Capital Management VI's portfolio in Q2 2026, its #6 holding.
  • Foresite Capital Management VI first reported a position in Agios Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Foresite Capital Management VI's 13F filing for Q2 2026, filed 14 Aug 2026.